IMCB Division of Cell and Molecular Therapy (CMT)
Biotechnology Research • 
Singapore • 1-10 Employees
Company overview
| Headquarters | Singapore |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
Key Contact at IMCB Division of Cell and Molecular Therapy (CMT)
Jo Brown
Business Development and Strategic Alliance Director
About IMCB Division of Cell and Molecular Therapy (CMT)
“Innovative and value-driven use of cells and molecular engineering to address complex Asian-centric diseases”
$
IMCB Division of Cell and Molecular Therapy (CMT) revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
IMCB Division of Cell and Molecular Therapy (CMT) has never raised funding before.
Australia
United States
Canada
Frequently asked questions
IMCB Division of Cell and Molecular Therapy (CMT) is located in SG.
IMCB Division of Cell and Molecular Therapy (CMT) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
